Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker

Fig. 2

Bulk MARCO expression in GBM is associated with poor clinical prognosis and mesenchymal subtype. MARCO expression in TCGA-GBM is associated with poorer overall survival (a) and disease-free survival (b). c, d Bulk MARCO expression also associates with IDH1-wild-type status. e TCGA-GBM expression subtyping shows an enrichment of MARCO with the mesenchymal subtype

Back to article page